Financial Performance - Operating revenue for Q1 2024 was CNY 284,309,844.38, a decrease of 26.99% year-on-year[12] - Net profit attributable to shareholders increased by 806.56% to CNY 9,931,547.83 compared to the same period last year[12] - Cash flow from operating activities showed a significant decline of 429.28%, resulting in a net outflow of CNY 70,949,432.04[12] - Total operating revenue for Q1 2024 was ¥284,309,844.38, a decrease of 27% compared to ¥389,407,863.35 in Q1 2023[42] - Net profit for Q1 2024 reached ¥9,923,140.14, significantly up from ¥1,095,516.05 in Q1 2023, marking an increase of 806%[44] - Operating revenue for Q1 2024 was approximately $294.55 million, a decrease of 22.5% compared to $379.71 million in Q1 2023[47] - Net profit for Q1 2024 reached approximately $9.72 million, compared to a net profit of $95,676.07 in Q1 2023[48] - Total comprehensive income for Q1 2024 was approximately $9.72 million, compared to $95,676.07 in Q1 2023[48] Assets and Liabilities - Total assets decreased by 7.45% to CNY 885,146,487.98 compared to the end of last year[12] - Total current assets decreased from ¥686,799,800.16 as of December 31, 2023, to ¥613,142,754.49 as of March 31, 2024, representing a decline of approximately 10.7%[36] - Total liabilities decreased from ¥313,764,391.39 to ¥237,521,339.29, reflecting a decline of about 24.3%[38] - Current liabilities decreased from ¥305,082,313.03 to ¥228,886,118.27, a decrease of approximately 25%[37] - The total assets decreased to ¥902,424,470.60 in Q1 2024 from ¥956,006,725.10 in Q1 2023, reflecting a decline of approximately 5.6%[41] - Total liabilities decreased to ¥280,292,882.81 in Q1 2024 from ¥343,597,353.51 in Q1 2023, a reduction of about 18.5%[41] Shareholder Information - The number of ordinary shareholders was reported at 3,037 as of the end of the reporting period[18] - The largest shareholder, Yao Hong, holds 22,855,369 shares, representing 13.95% of the total shares[20] - The total number of shares held by the top ten shareholders is 60,769,830, accounting for 37.09% of the total shares[21] - The company has established relationships among major shareholders, with Yao Hong and Lin Guiyan being spouses and acting in concert with other shareholders[21] Research and Development - Research and development expenses increased by 44.99% to CNY 2,314,482.63, reflecting the company's commitment to innovation[14] - Research and development expenses rose to ¥2,314,482.63 in Q1 2024, up from ¥1,596,322.19 in Q1 2023, indicating a 45% increase[42] Cash Flow and Financing Activities - The net cash flow from operating activities for Q1 2024 was approximately -$70.95 million, a significant decline from $21.55 million in Q1 2023[49] - The net cash flow from financing activities was $465,053.47, a sharp decline from $90.31 million previously[53] - Cash inflow from financing activities totaled $12.50 million, significantly lower than $93.58 million in the prior period[53] - The company raised approximately $60 million in borrowings during Q1 2024, compared to $35 million in Q1 2023[51] Other Financial Metrics - The weighted average return on equity based on net profit attributable to shareholders was 1.31%, up from 0.19% in the previous year[12] - Basic and diluted earnings per share for Q1 2024 were both ¥0.05, compared to ¥0.01 in Q1 2023, reflecting a 400% increase[45] - The company's retained earnings increased from ¥128,300,782.63 to ¥133,841,048.51, an increase of about 4.3%[38] - The deferred income tax liabilities decreased from ¥4,171.15 in Q1 2023 to ¥445.23 in Q1 2024, a decline of approximately 89.3%[41] Government Support - The company received government subsidies amounting to CNY 4,588,367.43, contributing positively to its financial performance[15] Legal and Compliance - There are no reported lawsuits or arbitration matters during the reporting period[24] - The company has fulfilled all disclosed commitments without any overdue obligations[30] - The company has no reported cases of asset seizure, freezing, or pledging beyond the disclosed amounts[29]
凯大催化(830974) - 2024 Q1 - 季度财报